Cell and gene therapy venture funding deal count year-over-year change vs Novel active substance launches

Cell and gene therapy venture funding deal count year-over-year change and Novel active substance launches worldwide, compared over time.

Change the pair

Compare different indicators

The series

Over time

Global, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

Cell and gene therapy venture funding deal count year-over-year change

Unit: % · 3 observations

Line chart
Cell and gene therapy venture funding deal count year-over-year changeCell and gene therapy venture funding deal count year-over-year change. 3 observations from 2021 to 2023, ranging from -24% to 57%. Latest value 19% (2023). % -40 -20 0 20 40 60 2004 2008 2012 2016 2020 2024 57% 19%
Cell and gene therapy venture funding deal count year-over-year changeCell and gene therapy venture funding deal count year-over-year change. 3 observations from 2021 to 2023, ranging from -24% to 57%. Latest value 19% (2023). % -30 0 30 60 2004 2008 2012 2016 2020 2024 57% 19%
Cell and gene therapy venture funding deal count year-over-year changeCell and gene therapy venture funding deal count year-over-year change. 3 observations from 2021 to 2023, ranging from -24% to 57%. Latest value 19% (2023). % -30 0 30 60 2004 2008 2012 2016 2020 2024 57% 19%
View the underlying data
Cell and gene therapy venture funding deal count year-over-year change
Period Type Value
2021 Actual 57%
2022 Actual -24%
2023 Actual 19%
Source: IQVIA · CC BY 4.0 · Full series

Novel active substance launches

Unit: count · 2 observations

Line chart
Novel active substance launchesNovel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025). 0 200 400 600 800 1,000 2004 2008 2012 2016 2020 2024 942 79
Novel active substance launchesNovel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025). 0 300 600 900 1,200 2004 2008 2012 2016 2020 2024 942 79
Novel active substance launchesNovel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025). 0 300 600 900 1,200 2004 2008 2012 2016 2020 2024 942 79
View the underlying data
Novel active substance launches
Period Type Value
2004–2023 Actual 942
2025 Actual 79
Source: IFPMA, IQVIA · CC BY 4.0 · Full series

Provenance

Where these numbers come from

Cell and gene therapy venture funding deal count year-over-year change

Percentage change in the number of cell and gene therapy venture capital and public funding deals versus the prior year.

3 observations in Global · source organisations: IQVIA

Novel active substance launches

Total number of novel active substances launched.

2 observations in Global · source organisations: IFPMA, IQVIA

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related